Literature DB >> 26904454

Dermatopathology quiz: A dome-shaped papule on the cheek.

Amira Elbendary1, Erick Jacobson2, Klaus Busam3, Dirk Elston4.   

Abstract

Entities:  

Year:  2015        PMID: 26904454      PMCID: PMC4738520          DOI: 10.4103/2229-5178.171039

Source DB:  PubMed          Journal:  Indian Dermatol Online J        ISSN: 2229-5178


× No keyword cloud information.
The 43-year-old woman was evaluated for a 0.4 cm erythematous, dome shaped papule on her left cheek. Clinically, an irritated or atypical nevus was suspected, and a shave biopsy of the lesion was performed. Histopathological sections revealed a compound, biphasic melanocytic neoplasm composed of both banal appearing nevus cells [Figure 1], and a second population of epithelioid melanocytes forming large dermal aggregates [Figures 2 and 3]. While the conventional component of the neoplasm demonstrated evidence of maturation and dispersion with descent into the dermis, the epithelioid component was monomorphic throughout and showed no evidence of maturation. An Elastic Van Gieson (EVG) stain showed retained elastic fibers within the epithelioid nests. A BRCA1 associated protein-1 (BAP1) immunohistochemical stain mirrored the dichotomous morphology, with nuclear staining in the conventional-appearing nevus cells and the absence of nuclear staining in the epithelioid cells [Figure 4]. Strong p16 staining was noted in the epithelioid component [Figure 5].
Figure 1

A large nodule of epithelioid melanocytes is embedded among small banal nevus cells

Figure 2

The epithelioid nodule is sharply circumscribed and the transition between the two populations is abrupt

Figure 3

The nuclei of the epithelioid cells are hyperchromatic and pleomorphic. They are unlike the vesicular nuclei with prominent central nucleoli noted in Spitz nevi

Figure 4

Nuclear BRCA1 Associated Protein-1 is expressed normally in the banal nevus population, but lost in the epithelioid population

Figure 5

The epithelioid cells strongly express p16

A large nodule of epithelioid melanocytes is embedded among small banal nevus cells The epithelioid nodule is sharply circumscribed and the transition between the two populations is abrupt The nuclei of the epithelioid cells are hyperchromatic and pleomorphic. They are unlike the vesicular nuclei with prominent central nucleoli noted in Spitz nevi Nuclear BRCA1 Associated Protein-1 is expressed normally in the banal nevus population, but lost in the epithelioid population The epithelioid cells strongly express p16 The most likely diagnosis is: Malignant melanoma arising in a congenital nevus Epithelioid Spitz nevus Wiesner nevus Metastatic, familial uveal melanoma involving a nevus Balloon-cell change in a congenital nevus. ANSWER: C. Wiesner nevus

DISCUSSION

Wiesner nevus is a benign epithelioid nevus with BAP1 mutation that represents a morphologically and genetically distinct variant in the spectrum of epithelioid Spitz nevi.[1] Clinically, the lesion typically presents as a skin colored or reddish-brown, well-circumscribed, dome-shaped papule. Alternatively, it may present as either rapid growth or pigmentary change within a preexisting nevus.[2] The lesions can arise as either isolated, sporadic lesions or as part of an autosomal dominant syndrome of familial uveal melanoma and benign cutaneous Weisner nevi (cutaneous BAPomas).[3] Histopathologically, routine hematoxylin and eosin stained sections of benign epithelioid nevi with BAP1 loss are characteristically biphasic in appearance with one component composed of dermal nests of epithelioid cells. Specifically, these are larger melanocytes with nuclei that are round to oval with open vesicular chromatin and distinct nucleoli and abundant amphophilic cytoplasm. In general, this cell population is surrounded by a second population of smaller, more banal appearing melanocytes.[4] Lack of maturation, reverse maturation, cytologic atypia with large hyperchromatic nuclei, and rare mitotic activity have all been reported in these nevi, separating them from other Spitz nevi.[5] At the molecular level, Wiesner nevi demonstrates biallelic loss of BAP1 via BAP1 germline mutation, in the familial cases, or postzygotic somatic mutation, in the sporadic nevi. The microscopic correlate to this molecular anomaly is the immunohistochemical loss of nuclear expression of BAP1 in the epithelioid cells.[2] It is important to note that in a subset of these nevi a clumped-perinuclear staining pattern was reported suggesting an abnormal localization of a nonfunctional or dysfunctional protein.[6] Differentiating benign epithelioid nevi with BAP1 loss from other entities in the differential diagnosis can be challenging. Epithelioid cells in Spitz nevus can show similar histologic features, but the absence of other characteristic features of a Spitz can be helpful in distinguishing between the two entities. Specifically, Spitz nevi typically demonstrate epidermal hyperplasia, hypergranulosis, clefting around junctional melanocytic nests and Kamino bodies. Spitz nevi mature and disperse with descent into the dermis, whereas Weisner nevi do not. At the molecular level, Wiesner nevi frequently have BRAF mutation in addition to the characteristic BAP1 mutation, a genetic finding absent in Spitz nevi.[2] Melanoma arising out of a preexisting nevus is the most important differential diagnosis of benign epithelioid nevi with BAP1 loss.[7] Both melanomas associated with congenital nevi and Wiesner nevi are biphasic neoplasms in which one cellular component is significantly larger and more atypical than the other. There are, however, clues present on routine hematoxylin and eosin stained sections that favor one diagnosis over the other. Whereas, Wiesner nevi maintain a nevoid growth pattern that does not displace dermal connective tissue, melanomas demonstrate an invasive pattern in which tumor stroma typically displaces normal dermal collagen and elastic fibers. Furthermore, Wiesner nevi only rarely have mitotic figures, whereas melanomas frequently have multiple cells in mitosis. Special stains may also help assess the growth pattern and proliferation fraction of a given neoplasm. Staining for dermal elastic fibers with an EVG stain can help identify elastic tissue that has been displaced (or “bulldozed”), by melanoma tumor stroma.[8] A dual differentiation and proliferation marker combination such as the Mart-1/Ki-67 double stain may also help distinguish the two entities. Ki-67 proliferation index <10% favors a diagnosis of melanoma.[9] When other findings are equivocal, fluorescence in situ hybridization or comparative genomic hybridization can also be useful in distinguishing Wiesner nevus from melanoma.[5] BRCA1 associated protein 1 is a tumor suppressor protein, which has a role in control of cell cycle progression at the G1/S check point, and its loss was found to have a role in tumor-genesis.[6] The increased susceptibility to develop uveal melanoma, mesothelioma, and renal cell carcinoma in patients with a germline mutation of BAP1is well documented.[2] However, sporadic BAP1-mutated nevi also occur in the absence of other evidence of a tumor syndrome. Data until date suggests that Wiesner nevi are benign lesions that mimic melanoma arising in conjunction with a preexisting nevus.[9] As long-term follow-up is limited, complete excision of isolated lesions is recommended by some authors. Patients with multiple lesions should be offered genetic counseling to address both inherited tumor susceptibility in offspring and to enhance early tumor detection and intervention.[1]

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  9 in total

Review 1.  The spitzoid lesion: the importance of atypical variants and risk assessment.

Authors:  Raymond L Barnhill
Journal:  Am J Dermatopathol       Date:  2006-02       Impact factor: 1.533

2.  Elastic fiber pattern in regressing melanoma: a histochemical and immunohistochemical study.

Authors:  Hideko Kamino; Sam Tam; Daniel Roses; Sonia Toussaint
Journal:  J Cutan Pathol       Date:  2010-02-24       Impact factor: 1.587

3.  Melanocytic nevi with an atypical epithelioid cell component: clinical, histopathologic, and fluorescence in situ hybridization findings.

Authors:  Pedram Pouryazdanparast; Zahra Haghighat; Beth Ann Beilfuss; Joan Guitart; Pedram Gerami
Journal:  Am J Surg Pathol       Date:  2011-09       Impact factor: 6.394

4.  A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression.

Authors:  Thomas Wiesner; Rajmohan Murali; Isabella Fried; Lorenzo Cerroni; Klaus Busam; Heinz Kutzner; Boris C Bastian
Journal:  Am J Surg Pathol       Date:  2012-06       Impact factor: 6.394

Review 5.  Tumours associated with BAP1 mutations.

Authors:  Rajmohan Murali; Thomas Wiesner; Richard A Scolyer
Journal:  Pathology       Date:  2013-02       Impact factor: 5.306

6.  Use of Bayes rule and MIB-1 proliferation index to discriminate Spitz nevus from malignant melanoma.

Authors:  Robin T Vollmer
Journal:  Am J Clin Pathol       Date:  2004-10       Impact factor: 2.493

7.  Clumped perinuclear BAP1 expression is a frequent finding in sporadic epithelioid Spitz tumors.

Authors:  Bryan Gammon; Tom N Traczyk; Pedram Gerami
Journal:  J Cutan Pathol       Date:  2013-03-15       Impact factor: 1.587

8.  Multiple epithelioid Spitz nevi or tumors with loss of BAP1 expression: a clue to a hereditary tumor syndrome.

Authors:  Klaus J Busam; Michelle Wanna; Thomas Wiesner
Journal:  JAMA Dermatol       Date:  2013-03       Impact factor: 10.282

9.  Germline mutations in BAP1 predispose to melanocytic tumors.

Authors:  Thomas Wiesner; Anna C Obenauf; Rajmohan Murali; Isabella Fried; Klaus G Griewank; Peter Ulz; Christian Windpassinger; Werner Wackernagel; Shea Loy; Ingrid Wolf; Agnes Viale; Alex E Lash; Mono Pirun; Nicholas D Socci; Arno Rütten; Gabriele Palmedo; David Abramson; Kenneth Offit; Arthur Ott; Jürgen C Becker; Lorenzo Cerroni; Heinz Kutzner; Boris C Bastian; Michael R Speicher
Journal:  Nat Genet       Date:  2011-08-28       Impact factor: 38.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.